Yiangou et al., 1985 - Google Patents
Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract: Nonequimolar levels of peptide histidine isoleucine and vasoactive …Yiangou et al., 1985
- Document ID
- 3567181221715455638
- Author
- Yiangou Y
- Christofides N
- Blank M
- Yanaihara N
- Tatemoto K
- Bishop A
- Polak J
- Bloom S
- Publication year
- Publication venue
- Gastroenterology
External Links
Snippet
Regional specific antibodies and chromatography were used to analyze the distributions and molecular forms of peptide histidine isoleucine (PHI) and vasoactive intestinal peptide (VIP) in the porcine intestine. Both peptides were present along the entire length of the …
- 101700003320 VIP 0 title abstract description 62
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones; against hormone releasing or inhibiting factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Yiangou et al. | Molecular forms of peptide histidine isoleucine-like immunoreactivity in the gastrointestinal tract: Nonequimolar levels of peptide histidine isoleucine and vasoactive intestinal peptide in the stomach explained by the presence of a big peptide histidine isoleucine-like molecule | |
Chang et al. | Radioimmunoassay of cholecystokinin | |
Eberlein et al. | A new molecular form of PYY: structural characterization of human PYY (3–36) and PYY (1–36) | |
US4895932A (en) | Method for determining cardiodilatin and fragments thereof and antibodies useful in determination of cardiodilatin and its fragments | |
Fahrenkrug et al. | VIP and PHI in cat neurons: co-localization but variable tissue content possible due to differential processing | |
CLEMENT-JONES et al. | Development of a specific extracted radioimmunoassay for methionine enkephalin in human plasma and cerebrospinal fluid | |
Ghatei et al. | Regulatory peptides in the mammalian respiratory tract | |
P. Skov et al. | Quantitation of epidermal growth factor in the rat: Identification and partial characterization of duodenal EGF | |
Minamino et al. | N-terminally extended form of C-type natriuretic peptide (CNP-53) identified in porcine brain | |
EP1628136A1 (en) | Method of diagnosis of disease using copeptin | |
Fahrenkrug et al. | Development and validation of a specific radioimmunoassay for PHI in plasma | |
CN101967190A (en) | Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 of probnp | |
Tateyama et al. | Characterization of immunoreactive brain natriuretic peptide in human cardiac atrium | |
Christofides et al. | Distribution of peptide histidine isoleucine in the mammalian respiratory tract and some aspects of its pharmacology | |
Netchitailo et al. | Localization and characterization of atrial natriuretic factor (ANF)-like peptide in the frog atrium | |
Ghatei et al. | Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas | |
TANAKA et al. | Presence of immunoreactive γ-melanocyte-stimulating hormone, adrenocorticotropin, and β-endorphin in human gastric antral mucosa | |
Orloff et al. | Accumulation of carboxy-terminal fragments of parathyroid hormone-related protein in renal failure | |
Ratcliffe et al. | Identification and partial characterization of parathyroid hormone-related protein in human and bovine milk | |
JPH04120094A (en) | Bird-originated novel physiologically active peptide (chicken cnp) | |
Aston et al. | Monoclonal antibodies to growth hormone and prolactin | |
Rahier et al. | Biosynthesis of gastrin: localization of the precursor and peptide products using electron microscopic-immunogold methods | |
Sekiya et al. | Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value. | |
Thody et al. | A radioimmunoassay for β-melanocyte-stimulating hormone in human plasma | |
Yiangou et al. | Peptide histidine-methionine immunoreactivity in plasma and tissue from patients with vasoactive intestinal peptide-secreting tumors and watery diarrhea syndrome |